The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,260.00
Ask: 2,270.00
Change: 0.00 (0.00%)
Spread: 10.00 (0.442%)
Open: 2,320.00
High: 2,320.00
Low: 2,250.00
Prev. Close: 2,265.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2018 09:28

RNS Number : 9602G
Morgan Sindall Group PLC
07 March 2018
 

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1.

Details of Restricted Person/person closely associated with them ("PCA")

a)

Name

John Morgan (Chief Executive)

Steve Crummett (Finance Director)

2.

Reason for the notification  

a)

Position/status

Members of the Board of directors

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)

LEI

2138008339ULDGZRB345

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 

ISIN: GB0008085614 

b)

Nature of the transaction

Grant of conditional awards over Ordinary Shares on 6 March 2018, under the Company's 2014 Long Term Incentive Plan, adopted by the Company on 30 July 2014 ("2014 LTIP"). Each conditional award will vest on 6 March 2021 subject to the satisfaction of performance criteria. Each conditional award carries a right to receive, on vesting, an amount linked to dividends paid on the Ordinary Shares subject to the conditional award. The dividend equivalent can be settled in cash or Ordinary shares of the Company.

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

John Morgan

N/A

61,666

Steve Crummett

N/A

49,171

d)

Aggregated information

- Aggregated volume

- Price

As above

 

e)

Date of the transaction

6 March 2018

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLIFFAVDIDIIT
Date   Source Headline
4th May 20187:00 amRNSAGM Trading Update
30th Apr 201810:17 amRNSTotal Voting Rights
23rd Apr 20189:15 amRNSBlock listing Interim Review
17th Apr 20187:00 amRNSMorgan Sindall Group Agrees £2bn Joint Venture
29th Mar 20185:29 pmRNSTotal Voting Rights
26th Mar 201812:25 pmRNSAnnual Financial Report
20th Mar 20182:38 pmRNSHolding(s) in Company
7th Mar 20189:28 amRNSDirector/PDMR Shareholding
7th Mar 20189:27 amRNSDirector/PDMR Shareholding
5th Mar 20183:49 pmRNSDirector/PDMR Shareholding
28th Feb 201811:19 amRNSTotal Voting Rights
26th Feb 20189:43 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
1st Feb 201810:45 amRNSTotal Voting Rights
30th Jan 20182:33 pmRNSHolding(s) in Company
29th Jan 20183:10 pmRNSDirectorate Change
15th Jan 201812:38 pmRNSStatement re: Carillion plc
8th Jan 20187:00 amRNSNotice of Results
3rd Jan 20189:08 amRNSTotal Voting Rights
14th Dec 20178:00 amRNSAdditional Listing
1st Dec 20171:00 pmRNSTotal Voting Rights
1st Dec 201712:37 pmRNSDirector/PDMR Shareholding
28th Nov 20175:13 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSPartnership Homes MOD Contract
24th Nov 20172:55 pmRNSHolding(s) in Company
22nd Nov 20177:00 amRNSAnalyst and Investor Evening Reception
2nd Nov 201712:50 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSTrading Update
31st Oct 20172:03 pmRNSTotal Voting Rights
27th Oct 201710:00 amRNSNotice of Trading Update
23rd Oct 20178:47 amRNSBlock listing Interim Review
2nd Oct 20179:05 amRNSTotal Voting Rights
21st Sep 20178:00 amRNSAdditional Listing
8th Sep 20173:27 pmRNSHolding(s) in Company
6th Sep 20175:22 pmRNSHolding(s) in Company
31st Aug 201712:16 pmRNSTotal Voting Rights
17th Aug 20171:14 pmRNSHolding(s) in Company
17th Aug 201711:12 amRNSHolding(s) in Company
8th Aug 20177:00 amRNSHalf-year Report
4th Aug 20178:45 amRNSHolding(s) in Company
31st Jul 201712:27 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSTrading Update
3rd Jul 20174:54 pmRNSHolding(s) in Company
3rd Jul 201710:31 amRNSTotal Voting Rights
23rd Jun 20177:00 amRNSNotice of Results
20th Jun 20177:00 amRNSMorgan Sindall contract extension worth up to £60m
6th Jun 20177:00 amRNSNotice of Capital Markets event and site visit
5th Jun 20179:04 amRNSHolding(s) in Company
31st May 201711:13 amRNSTotal Voting Rights
24th May 20178:30 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.